S016 Business and Leadership: What Dermatologists Should Know
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Medicine is one of the largest Businesses in the world. Most medical training does not involve learning about this important topic. In this session, Dermatologists and trainees will learn about various aspects of Business and Leadership in Medicine and Dermatology.
LEARNING OBJECTIVES
Summarize various business aspects of Dermatology and Medicine
Outline various practice settings for Dermatologists and Trainees
Recognize leadership perspectives in AAD and AMA
SCHEDULE
9:00 PM
How to run a successful Dermatology organization
Mark D. Kaufmann, MD, FAAD
9:15 PM
Business of Dermatology and Medicine
Keyvan Nouri, MBA, MD, FAAD
9:45 PM
Coding and billing in Medical Dermatology
Dirk Michael Elston, MD, FAAD
10:00 PM
Coding and billing in Surgical Dermatology
Howard Wooding Rogers, MD, PhD, FAAD
10:15 PM
How to run a successful Medical Dermatology Practice
Amy J McMichael, MD, FAAD
10:30 PM
How to run a successful Surgical/Cosmetic Dermatology Practice
Roy G. Geronemus, MD, FAAD
10:45 PM
How to run a successful Dermatopathology practice
Tammie C. Ferringer, MD, FAAD
11:00 PM
How to run a successful Pediatric Dermatology practice
Robert Sidbury, MD, MPH, FAAD
11:15 PM
Physician Leadership: Perspectives from the AMA President
Jack S. Resneck Jr., MD, FAAD
11:30 PM
How to get more involved in AAD Leadership
Marta Jane Van Beek, MD, MPH, FAAD
11:45 PM
Q&A
SPEAKERS
Dirk Michael Elston, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Roy G. Geronemus, MD, FAAD
Mark D. Kaufmann, MD, FAAD
Amy J McMichael, MD, FAAD
Keyvan Nouri, MBA, MD, FAAD
Jack S. Resneck Jr., MD, FAAD
Howard Wooding Rogers, MD, PhD, FAAD
Robert Sidbury, MD, MPH, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Roy G. Geronemus, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Cynosure, Inc – Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Advisory Board(Grants/Research Funding), Investigator(Stock), Stockholder(Stock); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);
Mark D. Kaufmann, MD, FAAD
Apogee Therapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Dermsquared – Other(Fees); DermTech Inc. – Consultant (1099 relationship)(Fees); Incyte – Consultant (1099 relationship)(Fees); Modernizing Medicine – Consultant(Stock); MoleSafe, Inc. – Other(Stock); Novan – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); Rise Healthcare Tech, Inc. – Advisory Board(Stock Options); Rivera Consulting – Consultant (1099 relationship)(Fees); ROM Technologies Inc. – Consultant (1099 relationship)(Stock); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees);
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Other Financial Benefit); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Jack S. Resneck Jr., MD, FAAD
No financial relationships exist with ineligible companies.
Howard Wooding Rogers, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Robert Sidbury, MD, MPH, FAAD
Arcutis, Inc. – Advisory Board(Honoraria); Beiersdorf, Inc. – Speaker/Faculty Education(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Dermavent – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma Global – Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(No Compensation Received); UCB – Investigator(Grants/Research Funding);
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.